Show simple item record

dc.contributor.authorGill, Christopher Jen
dc.contributor.authorSabin, Lora Len
dc.contributor.authorTham, Josephen
dc.contributor.authorHamer, Davidson Hen
dc.date.accessioned2012-06-26T01:38:01Z
dc.date.available2012-06-26T01:38:01Z
dc.date.created2004en
dc.date.issued2004en
dc.identifier.urihttps://apps.who.int/iris/handle/10665/72316
dc.descriptionSummaries in English, French, Spanish and Arabicen
dc.subject.meshTrimethoprim-sulfamethoxazole combinationen
dc.subject.meshPneumonia, Pneumocystisen
dc.subject.meshHIV Infectionsen
dc.subject.meshAIDS-Related Opportunistic Infectionsen
dc.subject.meshInfectious Disease Transmission, Verticalen
dc.subject.meshDrug Resistance, Microbialen
dc.subject.meshSulfadoxineen
dc.subject.meshPyrimethamineen
dc.subject.meshInfanten
dc.subject.meshRisk Assessmenten
dc.subject.meshMeta-Analysisen
dc.subject.meshModels, Theoreticalen
dc.subject.meshAfricaen
dc.subject.otherCommunicable Diseases and their Controlen
dc.titleReconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection / Christopher J. Gill ... [‎et al.]‎en
dc.title.alternativeRemise en question du traitement préventif empirique par le cotrimoxazole chez les nourrissons exposés à l' infection par le VIH : résuméen
dc.title.alternativeReconsideración de la profilaxix empírica con trimetoprim y sulfametoxazol en lactantes expuestos a la infección por VIH : resumenen
dc.typeJournal / periodical articles
dc.subject.meshqualifiertherapeutic use adverse effectsen
dc.subject.meshqualifierdrug therapyen
dc.subject.meshqualifiercomplicationsen
dc.subject.meshqualifierpharmaclogyen
dc.relation.ispartofjournalBulletin of the World Health Organization : the International Journal of Public Health 2004 ; 82(‎4)‎ : 290-298


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record